Chirality and Regulatory Affairs
Chirality and drugs
Article REF: P3340 V1
Chirality and Regulatory Affairs
Chirality and drugs

Author : Serge KIRKIACHARIAN

Publication date: March 10, 2005, Review date: January 1, 2021 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

6. Chirality and Regulatory Affairs

It would be tedious to give an exhaustive presentation of the directives governing the marketing of chiral drugs, which are specific to each country. Various meetings have been held on this subject, with the aim of reaching a general consensus wherever possible .

Extensive documentation on chiral drugs is available for Europe ...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Ongoing reading
Chirality and Regulatory Affairs

Article included in this offer

"Drugs and pharmaceuticals"

( 123 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us